Abstract
Acid sphingomyelinase (sphingomyelin phosphodiesterase, EC 3.1.4.12) was purified from human urine in the presence of 0.1 % Nonidet P-40. The activity could be enriched up to 30 000 fold by sequential chromatography on Octyl-Sepharose, Concanavalin-A Sepharose, Blue Sepharose and DEAE Cellulose. The last purification step yielded an enzyme preparation with a specific activity of about 2.5–10 mmol sphingomyelin cleaved/h per mg protein and with a yield of about 3–16 %. Purified sphingomyelinase appeared to be homogeneous in sodium dodecyl sulphate Polyacrylamide gel electrophoresis with a mass of about 70 kDa. In the presence of 0.08 % sodium taurodeoxycholate the preparation showed phosphodiesterase activity towards several phospholipids. Sphingomyelin, phosphatidylcholine, phosphatidylglycerol and at a slow rate phosphatidylethanolamine, phosphatidylinositol and phosphatidylserine were hydrolysed. The phospholipase C activity towards phosphatidylcholine and phosphatidylglycerol and acid sphingomyelinase activity copurified during the entire purification procedure, indicating that acid sphingomyelinase has phospholipase C activity towards these lipids.
Addition of 100 µM tripalmitoylglycerol to the assay system (which contains 100 µM sphingomyelin) instead of detergent, stimulated the reaction about 20-fold, thus offering a sensitive system for the assay of acid sphingomyelinase in a system free of detergents. Sphingomyelin degradation was strongly inhibited by phosphatidylinositol 4′, 5′-bis phosphate, adenosine 3′, 5′- diphosphate and adenine-9-β-D arabinofuranoside 5′-monophosphate (50 % inhibition at inhibitor concentrations of 1–5 µM and a substrate concentration of 100 µM sphingomyelin).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. N. Kanfer, O. Young, D. Shapiro and R. O. Brady, The metabolism of sphingomyelin. Purification and properties of a sphingomyelin-cleaving enzyme from rat liver tissue. J. B. C. 241:1081 (1966).
P. G. Pentchev, R. O. Brady, A. E. Gal and S. R. Hibbert, The isolation and characterisation of sphingomyelinase from human placental tissue, Biochim. Biophys. Acta 488:312 (1977).
C. S. Jones, P. Shankaran and J. W. Callahan, Purification of sphingomyelinase to apparent homogeneity by using hydrophobic chromatography, Biochem. J. 195:373 (1981).
N. Sakuragawa, Acid sphingomyelinase of human placenta: Purification, properties and 125iodine labeling, J. Biochem. 92:637 (1982).
T. Yamanaka and K. Suzuki, Acid sphingomyelinase of human brain: purification to homogeneity, J. Neurochem. 38:1753 (1982).
R. O. Brady, J. N. Kanfer, M. B. Mock and D. S. Fredrickson, The metabolism of sphingomyelin. Evidence of an enzymatic defect in Niemann-Pick disease, PNAS 55:366 (1966).
P. B. Schneider and E. P. Kennedy, Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. J. Lip. Res. 8:202 (1967).
A. L. Beaudet, M. S. Hampton, K. Patel and J. T. Sparrow, Acidic phospholipases in cultured human fibroblasts. Deficiency of phospholipase C in Niemann-Pick disease. Clin. Chim. Acta 108:403 (1980).
J. R. Wherrett and S. Huterer, Deficiency of taurocholate-dependent phospholipase C acting on phosphadidylcholine in Niemann-Pick disease, Neurolchem. Res. 8, No 1: 89 (1983).
S. Huterer, J. R. Wherrett, A. Poulos and J. W. Callahan, Deficiency of phospholipase C acting on phosphatidylglycerol in Niemann-Pick disease, Neurology 33:67 (1983).
S. F. Freeman, P. Shankaran, S. L. Wolfe and J. W. Callahan, Phosphatidylcholine and 4-methylumbelliferyl phosphorylcholine hydrolysis by purified placental sphingomyelinase, Can. J. Biochem. Cell Biol. 63:272 (1985).
G. Weitz, T. Lindl, U. Hinrichs and K. Sandhoff, Release of sphingomyelin phosphodiesterase (acid sphingomyelinase) by ammonium chloride from CL 1 D Mouse L-Cells and human fibroblasts, Hoppe-Seyler1s Z. Physiol. Chem. 364:863 (1983).
D. Scidel, J. Klenke, G. Fischer and H. Pilz, An improved and simple micro-method of sphingomyelinase assay in leukocytes and urine, J. Clin. Chem. Clin. Biochem. 16:407 (1978).
M. Driessen, G. Weitz, E. M. Brouwer-Kelder, W. E. Donker-Koopman, J. Bastiaannet, K. Sandhoff, J. A. Barranger, J. M. Tager and A. W. Schram, The effect of detergents on immunoprecipitability of lysosomal sphingomyelinase. BBA 841:97 (1985).
G. Weitz, L. E. Quintern, A. W. Schram, J. A. Barranger, J. M. Tager and K. Sandhoff, Purification and properties of acid sphingomyelinase from huma urine, in: “Enzymes of Lipid Metabol. II”, L. Freysz, H. Dreyfus, R. Massarelli and S. Gatt, eds., Plenum Press, New York, London, 261–266 (1986)
B. G. Rao and M. W. Spence, Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0, J. Lip. Res. 17:506 (1976).
J.W. Callahan, C. S. Jones, D. J. Davidson and P. Shankaran, The active site of lysosomal sphingomyelinase: Evidence for the involvement of hydrophobic and ionic groups. J. Neurose. Res. 10:151 (1983).
C. S. Jones, P. Shankaran, D. J. Davidson, A. Poulos and J. W. Callahan, Studies on the structure of sphingomyelinase: Amino acid composition and heterogeneity on isoelectric focusing, Biochem. J. 209:291 (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this paper
Cite this paper
Quintern, L.E., Nehrkorn, H., Sandhoff, K., Weitz, G., Tager, J.M., Schram, A.W. (1988). Acid Sphingomyelinase from Human Urine: Purification and Characterisation. In: Salvayre, R., Douste-Blazy, L., Gatt, S. (eds) Lipid Storage Disorders. NATO ASI Series, vol 150. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1029-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1029-7_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8300-3
Online ISBN: 978-1-4613-1029-7
eBook Packages: Springer Book Archive